ATC Group: R06AB04 Chlorphenamine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R06AB04 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R06 Antihistamines for systemic use
3 R06A Antihistamines for systemic use
4 R06AB Substituted alkylamines
5 R06AB04 Chlorphenamine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 12 mg
PAREN - Parenteral 12 mg

Active ingredients in R06AB04

Active Ingredient Description
Chlorphenamine

Chlorphenamine is a potent antihistamine (H1-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H1-receptor sites on tissues. Chlorphenamine also has anticholinergic activity.

Related product monographs

Title Information Source Document Type  
HAYLEVE Tablet MPI, EU: SmPC
RHINETON Tablet Health Products Regulatory Authority (ZA) MPI, Generic

Medicines in this ATC group

Ecuador (EC)

Israel (IL)

Malta (MT)

Mexico (MX)

New Zealand (NZ)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.